Neovasc Inc. Net Income Common

Net Income Common of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Income Common growth rates and interactive chart. Net income to common (NIC), also called net profit to shareholders, is calculated as sales minus cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes, and other expenses incuding preferred dividends. It is a useful number for investors to assess how much revenue exceeds the expenses of an organization.


Highlights and Quick Summary

  • Net Income Common for the quarter ending March 31, 2022 was $-10.2 Million (a 66.34% increase compared to previous quarter)
  • Year-over-year quarterly Net Income Common increased by 13.59%
  • Annual Net Income Common for 2021 was $-24.6 Million (a -18.93% decrease from previous year)
  • Annual Net Income Common for 2020 was $-30.3 Million (a -15.48% decrease from previous year)
  • Annual Net Income Common for 2019 was $-35.9 Million (a -65.16% decrease from previous year)
  • Twelve month Net Income Common ending March 31, 2022 was $-32.7 Million (a 32.3% increase compared to previous quarter)
  • Twelve month trailing Net Income Common increased by 26.23% year-over-year
Trailing Net Income Common for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$-32.7 Million $-24.7 Million $-23.1 Million $-25.9 Million
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Income Common of Neovasc Inc.

Most recent Net Income Commonof NVCN including historical data for past 10 years.

Interactive Chart of Net Income Common of Neovasc Inc.

Neovasc Inc. Net Income Common for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-10.16
2021 $-6.11 $-7.48 $-8.94 $-2.18 $-24.57
2020 $-4.54 $-10.23 $-9.93 $-4.11 $-30.31
2019 $-12.35 $-6.2 $-7.96 $-8.62 $-35.86
2018 $11.68 $-14.64 $-49.15 $-55.88 $-102.91
2017 $-5.03 $-4.7 $-5.34 $-7.85 $-23.79
2016 $37.21 $-29.14 $-83.69 $-10.88 $-86.49
2015 $-7.38 $-7.65 $-6.75 $-4.96 $-26.73
2014 $-6.06 $-4.05 $-5.92 $-0.35 $-17.18
2013 $-2.15 $-1.39 $-1.21 $-1.85 $-6.55
2012 $3.64 $-1.21 $-1.5 $-1.26 $-0.35
2011 $-0.99 $-3.86

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.